research on chinese medicine

• Search by keyword
• Search by citation

Page 1 of 24

Metabolomics integrated with network pharmacology of blood-entry constituents reveals the bioactive component of Xuefu Zhuyu decoction and its angiogenic effects in treating traumatic brain injury

Xuefu Zhuyu decoction (XFZYD) has been extensively utilized to treat traumatic brain injury (TBI). However, the bioactive compounds and the underlying mechanisms have not yet been elucidated.

• View Full Text

Qin-Yu-Qing-Chang decoction reshapes colonic metabolism by activating PPAR-γ signaling to inhibit facultative anaerobes against DSS-induced colitis

Qin-Yu-Qing-Chang decoction (QYQC), an herbal formula from China, is extensively employed to manage ulcerative colitis (UC) and exhibits potential benefits for colonic function. Nevertheless, the fundamental m...

Mechanism of norcantharidin intervention in gastric cancer: analysis based on antitumor proprietary Chinese medicine database, network pharmacology, and transcriptomics

Combining antitumor proprietary Chinese medicine (pCm) with radiotherapy and chemotherapy can effectively improve tumor cure rates and enhance patients’ quality of life. Gastric cancer (GC) severely endangers ...

The improvement of modified Si-Miao granule on hepatic insulin resistance and glycogen synthesis in type 2 diabetes mellitus involves the inhibition of TNF-α/JNK1/IRS-2 pathway: network pharmacology, molecular docking, and experimental validation

Modified Si-Miao granule (mSMG), a traditional Chinese medicine, is beneficial for T2DM and insulin resistance (IR), but the underlying mechanism remains unknown.

Machine learning-assisted rapid determination for traditional Chinese Medicine Constitution

The aim of this study was to develop a machine learning-assisted rapid determination methodology for traditional Chinese Medicine Constitution. Based on the Constitution in Chinese Medicine Questionnaire (CCMQ...

Buqi-Huoxue-Tongnao decoction drives gut microbiota-derived indole lactic acid to attenuate ischemic stroke via the gut-brain axis

Ischemic stroke belongs to “apoplexy” and its pathogenesis is characterized by qi deficiency and blood stasis combining with phlegm-damp clouding orifices. Buqi-Huoxue-Tongnao decoction (BHTD) is a traditional...

DMDD, isolated from Averrhoa carambola L., ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-autophagy crosstalk

Studies have shown that Averrhoa carambola L. possesses therapeutic potential for diabetes and related complications. However, the specific beneficial effects and molecular mechanisms of 2-dodecyl-6-meth-oxycyclo...

Calculating the similarity between prescriptions to find their new indications based on graph neural network

Drug repositioning has the potential to reduce costs and accelerate the rate of drug development, with highly promising applications. Currently, the development of artificial intelligence has provided the fiel...

Application of omics technologies in studies on antitumor effects of Traditional Chinese Medicine

Traditional Chinese medicine (TCM) is considered to be one of the most comprehensive and influential form of traditional medicine. It plays an important role in clinical treatment and adjuvant therapy for canc...

Screening of herbal extracts binding with vascular endothelial growth factor by applying HerboChip platform

Traditional Chinese medicine (TCM) has been hailed as a rich source of medicine, but many types of herbs and their functions still need to be rapidly discovered and elucidated. HerboChip, a target-based drug s...

Uncover the anticancer potential of lycorine

Natural products have a long history in drug discovery. Lycorine is an alkaloid derived from Amaryllidaceae plants, demonstrating significant pharmacological potential. Lycorine and its hydrochloride salt, lycori...

Targeting lipid droplets and lipid droplet-associated proteins: a new perspective on natural compounds against metabolic diseases

Lipid droplet (LD) is a metabolically active organelle, which changes dynamically with the metabolic state and energy requirements of cells. Proteins that either insert into the LD phospholipid monolayer or ar...

Astragali radix (Huangqi): a time-honored nourishing herbal medicine

Astragali radix (AR, namded Huangqi in Chinese) is the dried root of Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao or Astragalus membranaceus (Fisch.) Bge. As a widely used ethnomedicine, th...

Britannilactone 1-O-acetate induced ubiquitination of NLRP3 inflammasome through TRIM31 as a protective mechanism against reflux esophagitis-induced esophageal injury

Reflux esophagitis (RE) is a disease in which inflammation of the esophageal mucosa owing to the reflux of gastric contents into the esophagus results in cytokine damage. Britannilactone 1-O-acetate (Brt) has ...

Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer

Danggui Buxue (DGBX) decoction is a classical prescription composed of Astragali Radix (AR) and Angelicae Sinensis Radix (ASR), used to enrich blood, and nourish Qi in Chinese medicine, with the potential to r...

Correction: Cucurbitacin B inhibits TGF-β1-induced epithelial–mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways

The original article was published in Chinese Medicine 2022 17 :24

Correction: Bridging cultures: Chinese elements in scientific illustrations

The original article was published in Chinese Medicine 2024 19 :103

Comprehensive biomarker analysis of metabolomics in different syndromes in traditional Chinese medical for prediabetes mellitus

Prediabetes mellitus (PreDM) is a high-risk state for developing type 2 diabetes mellitus (T2DM) and often goes undiagnosed, which is closely associated with obesity and characterized by insulin resistance tha...

Polyphyllin I exerts anti-hepatocellular carcinoma activity by targeting ZBTB16 to activate the PPARγ/RXRα signaling pathway

Studies have reported that polyphyllin I (PPI) had effective anti-tumor activity against hepatocellular carcinoma (HCC). However, the precise molecular mechanism of this action and the direct target remain unc...

Dipeptide PA3264 derived from rare and endangered Squama Manis is a novel bioactive peptide for the treatment of triple-negative breast cancer

Squama Manis is a valuable traditional Chinese medicine with a long history of medicinal use in the treatment of breast-related diseases. However, owing to the excessive exploitation and utilization of the res...

Geniposide for treating atherosclerotic cardiovascular disease: a systematic review on its biological characteristics, pharmacology, pharmacokinetics, and toxicology

In recent years, the prevalence and fatality rates of atherosclerotic cardiovascular disease have not only shown a consistent rise that cannot be ignored, but have also become a pressing social health problem ...

Natural products for enhancing the sensitivity or decreasing the adverse effects of anticancer drugs through regulating the redox balance

Redox imbalance is reported to play a pivotal role in tumorigenesis, cancer development, and drug resistance. Severe oxidative damage is a general consequence of cancer cell responses to treatment and may caus...

Buyang Huanwu decoction ameliorates myocardial injury and attenuates platelet activation by regulating the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway

Buyang Huanwu Decoction (BYHWD) is a traditional Chinese medicine to treat the syndrome of qi deficiency and blood stasis. Platelets play an important role in regulating thrombus and inflammation after ischemi...

Electroacupuncture negatively regulates the Nesfatin-1/ERK/CREB pathway to alleviate HPA axis hyperactivity and anxiety-like behaviors caused by surgical trauma

Hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis constitutes a pivotal response by surgical trauma, manifesting as a critical aspect of the acute stress reaction. This hyperactivity resulted in a...

Total tanshinones ameliorates cGAS-STING-mediated inflammatory and autoimmune diseases by affecting STING-IRF3 binding

An important signaling pathway connecting illness and natural immunity is the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway, but aberrant activation of this pathway is associate...

Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model

The original article was published in Chinese Medicine 2021 16 :18

Shirebi granules ameliorate acute gouty arthritis by inhibiting NETs-induced imbalance between immunity and inflammation

Acute gouty arthritis (AGA) is classified as ‘arthritis’ in traditional Chinese medicine (TCM) theory. Shirebi granules (SGs), derived from the classic prescription SiMiaoWan, exerts satisfying therapeutic eff...

The analgesic effects of Yu-Xue-Bi tablet (YXB) on mice with inflammatory pain by regulating LXA4-FPR2-TRPA1 pathway

Oxylipins including lipoxin A4 (LXA4) facilitate the resolution of inflammation and possess analgesic properties by inhibiting macrophage infiltration and transient receptor potential (TRP) protein expression....

Bridging cultures: Chinese elements in scientific illustrations

In the context of globalization, the integration of cultural elements into scientific research, particularly through the incorporation of traditional Chinese cultural motifs in scientific illustrations, repres...

The Correction to this article has been published in Chinese Medicine 2024 19 :115

Biosynthesis and signal transduction of plant growth regulators and their effects on bioactive compound production in Salvia miltiorrhiza (Danshen)

Plant growth regulators (PGRs) are involved in multiple aspects of plant life, including plant growth, development, and response to environmental stimuli. They are also vital for the formation of secondary met...

Sound as a bell: a deep learning approach for health status classification through speech acoustic biomarkers

Human health is a complex, dynamic concept encompassing a spectrum of states influenced by genetic, environmental, physiological, and psychological factors. Traditional Chinese Medicine categorizes health into...

Theoretical exploring of potential mechanisms of antithrombotic ingredients in danshen-chishao herb-pair by network pharmacological study, molecular docking and zebrafish models

Salvia miltiorrhiza (Danshen, DS) and Radix Paeoniae Rubra (Chishao, CS) herbal pair (DS-CS) is a famous traditional Chinese combination which has been used as antithrombotic formular for centuries. However, t...

Deciphering the benefits and intensity levels of primary metabolites from Allium macrostemon Bunge and Allium chinense G. Don

Allii Macrostemonis Bulbus is also named Xiebai in China. It is an edible vegetable, and also a famous herb for treating coronary heart disease. Allium chinense G. Don (ACGD) and Allium macrostemon Bunge (AMB) ar...

Santalum album L. alleviates cardiac function injury in heart failure by synergistically inhibiting inflammation, oxidative stress and apoptosis through multiple components

Heart failure (HF) is a complex cardiovascular syndrome with high mortality. Santalum album L. (SAL) is a traditional Chinese medicine broadly applied for various diseases treatment including HF. However, the pot...

Pharmacological activity and clinical application analysis of traditional Chinese medicine ginger from the perspective of one source and multiple substances

All types of ginger have common fundamental components, although they possess distinct strengths and inclinations when it comes to effectiveness and medicinal applications. Fresh ginger possesses the ability t...

Application of 3D bioprinting technology apply to assessing Dangguiniantongtang (DGNT) decoctions in arthritis

The aim of this study was to develop a three-dimensional (3D) cell model in order to evaluate the effectiveness of a traditional Chinese medicine decoction in the treatment of arthritis. Chondrocytes (ATDC5) a...

Rhei Undulati Rhizoma attenuates memory decline and reduces amyloid-β induced neuritic dystrophy in 5xFAD mouse

Alzheimer's disease (AD) is a common type of dementia characterized by amyloid-β (Aβ) accumulation, lysosomal dysfunction, and tau hyperphosphorylation, leading to neurite dystrophy and memory loss. This study...

An optimal combination of four active components in Huangqin decoction for the synergistic sensitization of irinotecan against colorectal cancer

Irinotecan (CPT-11) is a first-line treatment for advanced colorectal cancer (CRC). Four components (baicalin, baicalein, wogonin, and glycyrrhizic acid) derived from Huangqin Decoction (HQD) have been proven ...

Therapeutic potentials of allicin in cardiovascular disease: advances and future directions

Cardiovascular disease (CVD) remains the predominant cause of mortality and disability worldwide. Against this backdrop, finding effective drugs for the pharmacological treatment of CVD has become one of the m...

G protein-coupled receptors and traditional Chinese medicine: new thinks for the development of traditional Chinese medicine

G protein-coupled receptors (GPCRs) widely exist in vivo and participate in many physiological processes, thus emerging as important targets for drug development. Approximately 30% of the Food and Drug Adminis...

Angelicin improves osteoporosis in ovariectomized rats by reducing ROS production in osteoclasts through regulation of the KAT6A/Nrf2 signalling pathway

Angelicin, which is found in Psoralea, can help prevent osteoporosis by stopping osteoclast formation, although the precise mechanism remains unclear.

Development of an artificial intelligent model for pre-endoscopic screening of precancerous lesions in gastric cancer

Given the high cost of endoscopy in gastric cancer (GC) screening, there is an urgent need to explore cost-effective methods for the large-scale prediction of precancerous lesions of gastric cancer (PLGC). We ...

Phytotherapeutic potential against MRSA: mechanisms, synergy, and therapeutic prospects

Rising resistance to antimicrobials, particularly in the case of methicillin-resistant Staphylococcus aureus (MRSA), represents a formidable global health challenge. Consequently, it is imperative to develop new ...

Nrf2 mediates the effects of shionone on silica-induced pulmonary fibrosis

Extended contact with silica particles can lead to Silicosis, a chronic lung condition lacking established treatment protocols or clear mechanisms of development. The urgency for innovative treatments arises f...

Shaoyao Decoction reduced T lymphocyte activation by regulating of intestinal flora and 5-hydroxytryptamine metabolism in ulcerative colitis

Shaoyao Decoction (SYD) is a widely recognized herbal formula utilized in traditional Chinese medicine for the treatment of diarrhea. Although it has demonstrated significant effectiveness in clinical practice...

β-elemene promotes microglial M2-like polarization against ischemic stroke via AKT/mTOR signaling axis-mediated autophagy

Resident microglia- and peripheric macrophage-mediated neuroinflammation plays a predominant role in the occurrence and development of ischemic stroke. Microglia undergo polarization to M1/M2-like phenotype un...

Liguzinediol potentiates the metabolic remodeling by activating the AMPK/SIRT3 pathway and represses Caspase-3/GSDME-mediated pyroptosis to ameliorate cardiotoxicity

Liguzinediol (Lig) has emerged as a promising candidate for mitigating Doxorubicin (DOX)-induced cardiotoxicity, a significant limitation in the clinical application of this widely used antineoplastic drug kno...

The effect of modified Qiyuan paste on mice with low immunity and sleep deprivation by regulating GABA nerve and immune system

Low immunity and sleep disorders are prevalent suboptimal health conditions in contemporary populations, which render them susceptible to the infiltration of pathogenic factors. LJC, which has a long history i...

Xinbao Pill ameliorates heart failure via regulating the SGLT1/AMPK/PPARα axis to improve myocardial fatty acid energy metabolism

Heart failure (HF) is characterized by a disorder of cardiomyocyte energy metabolism. Xinbao Pill (XBW), a traditional Chinese medicine formulation integrating “Liushen Pill” and “Shenfu Decoction,” has been a...

Improvement effects of a novel Chinese herbal formula in imiquimod and IL-23-stimulated mouse models of psoriasis

Psoriasis is a long-term inflammatory skin disease. A novel herbal formula containing nine Chinese herbal medicines, named Inflammation Skin Disease Formula (ISDF), has been prescribed in clinics for decades.

• Editorial Board
• Manuscript editing services
• Instructions for Editors
• Sign up for article alerts and news from this journal
• ISSN: 1749-8546 (electronic)

Chinese Medicine

ISSN: 1749-8546

• Submission enquiries: Access here and click Contact Us
• General enquiries: [email protected]

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings

The PMC website is updating on October 15, 2024. Learn More or Try it out now .

• Advanced Search
• Journal List
• Evid Based Complement Alternat Med
• v.2015; 2015

Developing Traditional Chinese Medicine in the Era of Evidence-Based Medicine: Current Evidences and Challenges

Foon yin fung.

1 Traditional Medicine Information Service, Department of Pharmacy, Singapore General Hospital, Singapore

Yeh Ching Linn

2 Department of Haematology, Singapore General Hospital, Academia, 20 College Road, Singapore 169856

Evidence-based medicine (EBM), by integrating individual clinical expertise with the best available clinical evidence from systematic research, has in recent years been established as the standard of modern medical practice for greater treatment efficacy and safety. Traditional Chinese Medicine (TCM), on the other hand, evolved as a system of medical practice from ancient China more than 2000 years ago based on empirical knowledge as well as theories and concepts which are yet to be mapped by scientific equivalents. Despite the expanding TCM usage and the recognition of its therapeutic benefits worldwide, the lack of robust evidence from the EBM perspective is hindering acceptance of TCM by the Western medicine community and its integration into mainstream healthcare. For TCM to become an integral component of the healthcare system so that its benefits can be rationally harnessed in the best interests of patients, it is essential for TCM to demonstrate its efficacy and safety by high-level evidence in accordance with EBM, though much debate remains on the validity and feasibility of applying the EBM model on this traditional practice. This review aims to discuss the current status of research in TCM, explore the evidences available on its efficacy and safety, and highlight the issues and challenges faced in applying EBM to TCM.

1. Introduction

Evidence-based medicine (EBM) is defined as “the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients.” The practice of evidence-based medicine means integrating individual clinical expertise with the best available external clinical evidence from systematic research [ 1 ]. In just over two decades since its first introduction, the EBM movement has created a paradigm shift to become the standard of modern medical practice, elevating it to a higher level and with greater accuracy, efficacy, and safety.

Traditional Chinese Medicine (TCM), on the other hand, evolved as a system of medical practice from ancient China more than 2000 years ago. In contrast to the disease-targeted approach adopted by Western medicine where there is a standard treatment protocol defined for each disease entity, TCM takes a holistic approach in treating the individual with customized treatment based on the concept of “Syndrome Differentiation.” The basic theories of TCM were derived from the Chinese philosophy of Yin-Yang and Five Elements, and its fundamental concepts such as the Zang-fu (viscera) concept, Qi (vital energy), and meridians have yet to be mapped by scientific equivalents or clearly elucidated in scientific terms.

While TCM is widely practiced in Asian populations such as China, Hong Kong, Taiwan, and Singapore, many non-Asian countries have, in recent decades, also recognized the huge therapeutic potential of this traditional practice and have been actively tapping into the benefits of TCM so as to provide patients with an additional option in their health management. In 1991, a TCM hospital was opened in KoÈtzting, Germany, whereby trained TCM physicians from China administered treatment according to the traditional practice [ 2 ]. In the United States, UCLA Center for East-West Medicine was founded in 1993 to provide integrative medicine treatment [ 3 ]. In 1998, the National Institutes of Health within the US Department of Health and Human Services set up the National Center for Complementary and Alternative Medicine with the mission to “define, through rigorous scientific investigation, the usefulness and safety of complementary and alternative medicine interventions (including TCM) and their roles in improving health and health care” [ 4 ]. In 2007, the National Institute of Complementary Medicine at the University of Western Sydney was established by the Australian and New South Wales Governments with a research focus on Chinese medicine via laboratory analysis, clinical trials, and translation into practice [ 5 ]. In 2014, Cleveland Clinic opened a hospital-based Chinese herbal therapy clinic in their Center for Integrative Medicine to provide supplementary options for patients seeking a holistic, natural approach to their care [ 6 ]. According to interim data from 2nd WHO TRM global survey as of 11 June 2012, 80% of the 129 member states now accept the use of acupuncture as a treatment modality [ 7 ].

Despite the growing prevalence of TCM usage and the worldwide interest in its therapeutic benefits, the fundamental issue hindering its acceptance by the Western medicine community and integration into mainstream healthcare is still the lack of robust evidence from the EBM perspectives. In order for TCM to be rationally used for patients who may benefit from it, it is essential for TCM to demonstrate its efficacy and safety by high-level evidence using methods which are accepted in the evaluation of mainstream medicine, that is, in accordance with evidence-based medicine. In the EBM system, different types of evidences are prioritized into a set of hierarchical levels. Randomized controlled trials (RCTs) or systematic reviews of RCTs are the golden standard for the highest level of evidence, followed by other types of evidences such as cohort studies, case-control studies, case series, case reports, animal/ in vitro studies, and expert opinion. Whether the EBM model can be applied to TCM has long been a subject of debate and an area where much effort has been focused on.

This review aims at (1) discussing the current status of research in TCM, (2) exploring the evidences available on the efficacy and safety of Chinese herbal medicine and acupuncture, and (3) highlighting the issues and challenges faced in applying EBM to TCM.

2. Current Status of Research on TCM Intervention

Vast amount of basic research has been conducted on TCM herbs, mostly in characterizing the multiple-herb constituents, isolating active components from the herbs, and testing their pharmacological activities in the pursuit of new drug discovery. The US Pharmacopeial Convention published the Herbal Medicines Compendium, which is an online database that provides such standards for herbs. Each herbal monograph contains specifications including tests for critical quality attributes of the herbal ingredient, as well as analytical test procedures and acceptance criteria for specified tests [ 8 ]. In China, the TCM systems of pharmacology database and analysis platform were developed as a comprehensive source of herb pharmacochemistry, pharmacokinetic properties, and so forth to help drive drug discovery from herbal sources [ 9 ]. Two famous examples of active ingredients effectively extracted from TCM and since proven to be clinically successful are artesunate derived from Artemisia annua used for severe malaria [ 10 , 11 ] and arsenic trioxide used for treatment of acute promyelocytic leukaemia [ 12 , 13 ]. Taking up the challenge of fulfilling the stringent requirements of good clinical practice, a few TCM formulations are currently undergoing FDA clinical trials. These include Danshen dripping pill ( Salvia miltiorrhiza , Radix notoginseng , and Borneol) for stable angina in phase III trial, Kanglaite injection (coix seed oil and excipients) for cancer, Xuezhikang capsule (red yeast) for hyperlipidemia, and Fuzheng Huayu capsule ( Salvia miltiorrhiza , peach seed, pine pollen, Gynostemma pentaphylla , and Schisandra chinensis ) for liver fibrosis in phase II trials [ 14 ].

Quantitatively, there is no shortage of clinical studies in TCM conducted worldwide. A search on the Clinicaltrials.gov found 436 trials on TCM and 607 acupuncture trials globally (as of November 2014), while a search on online scientific journal portals, for example, Pubmed, Chinese National Knowledge Infrastructure (CNKI), yielded more than ten thousand research papers covering a wide spectrum of research topics studying TCM from various approaches. The critical problem, however, lies in the dearth of good quality evidence and lack of strong research rigor in the plethora of studies published, which undermine the credibility of the evidences.

A screening of all the TCM-related systematic reviews published by the Cochrane database to date found that almost all of the reviews commented on the lack of high quality clinical trials done with good methodology, thereby negating any definitive conclusion on the efficacy of herbal or acupuncture interventions. Some of the specific criticisms cited in these reviews included lack of trials that tested the same herbal medicine, lack of details on cointerventions, unclear methods of randomisation, poor reporting, high risks of bias, and the need for well-designed and conducted trials with sufficient numbers of participants to perform subgroup analyses [ 15 ]. The lament on the suboptimal quality of clinical studies on TCM was also echoed by two systematic reviews of reports on RCTs of TCM published in China from 1999 to 2004 and those indexed in the CNKI database from 2005 to 2012, respectively. The former found that the mean Jadad score (a scoring system for the methodology quality of a clinical trial on a scale of 0 to 5) of the 7422 RCTs identified was 1.03 overall, with a mean score of only 0.85 in 1999 (746 RCTs) and 1.20 in 2004 (1634 RCTs) [ 16 ]. The latter concluded that although the quality of reporting RCTs of TCM has improved in 2011-2012 (2861 trials) compared to 2005–2009 (4133 trials), the percentages of high quality reports remained low-mean Jadad scores of 1.22 versus 1.25, with only 15.15% and 19.71% of the reports having a score of 2 [ 17 ]. These results highlighted the present state of huge disparity between the quantity and quality of TCM RCTs and demonstrated that much more work needs to be done to improve on the latter aspect.

3. Some Challenges of Applying EBM to TCM Clinical Trials

One fundamental challenge in conducting valid RCTs in TCM is the batch-to-batch variation of the active constituents contained in the herbal formulation used. Product-to-product variation arising from different manufacturers, brands, or formulation further hinders the fair comparison of the findings among similar studies. Such inconsistencies may result in lack of reproducibility between clinical trials and even challenge the validity of generalizing the findings of clinical trials to routine use. However this is something that can potentially be overcome by technological advancement. Newly developed analytical tools and techniques have made it possible to profile the constituents of herbs, for example, by using high-pressure liquid chromatography to establish a chemical fingerprint of the herb, where the profiles of different batches can be compared to ensure no significant variability [ 18 ]. Precise reporting of such information by clinical trials has to be implemented to assure validity of TCM trials. In parallel, legislation to define the required standard of proprietary products will eventually be required for acceptance of the clinical trial findings and efficacy of TCM products by the Western medicine practitioners.

Another challenge is the difficulty in creating an appropriate placebo for multiple-herb herbal decoctions, which compromises the effectiveness of blinding. While it is feasible to create placebos for capsules, pills, and tablets, it is technically challenging to create an indistinguishable placebo for a multiple-herb formulation in the form of decoction. However, with multiple-herb formulations in the form of granules being more favored over decoction due to its convenience of use, it is not impossible to overcome the aforementioned challenge. In addressing this need for good quality placebo in TCM clinical research, one recent research in China has described a novel technique which claims feasibility in creating a good quality placebo in granule form that has similar appearance, smell, and taste as the original preparation but with no pharmacological activity [ 19 ]. Besides herbal medicine, designing appropriate placebo for acupuncture trials is yet another challenge, though researchers have come up with various control measures such as nonacupuncture inert controls, placebo acupuncture, sham acupuncture, real acupuncture with a decoy treatment, waiting list controls, standard care controls, and adjunctive care comparisons [ 20 ].

Incorporating TCM principles in an RCT poses another challenge as it appears that the standardized treatment approach required by RCTs is in discordance with the individualized treatment approach inherent in TCM practice. This difference in approach, however, is not entirely irreconcilable. In order to accommodate TCM principle, that is, replicating the diagnosis using “Syndrome Differentiation” and giving the corresponding individualized treatment within the rigorous framework of EBM, a systematic process for assessing symptoms and signs, the identification, and the quantification of TCM syndrome for a sample group of study subjects with the same Western medical diagnosis can be applied before and after treatment [ 21 ]. To quantify a syndrome for diagnosis, the signs and symptoms of each subject could be tabulated and matched against the typical signs and symptoms which characterize a particular TCM syndrome. The percentage match between the two could then serve as the score for a certain syndrome and a corresponding treatment protocol would be administered, allowing an “individualized” treatment in a standardized and reproducible way [ 21 ]. One way of assessing the intervention effects could be done by comparing the change in scores.

4. Efforts to Improve the Quality of TCM Research

It is encouraging that the need to modernize the methodology of clinical trials in TCM is being recognized and actively addressed. A group of Chinese medicine researchers, practitioners, journal editors, and epidemiologists have established the Chinese CONSORT Group for TCM and proposed the Consolidated Standards for Reporting Trials (CONSORT) of Traditional Chinese Medicine [ 22 ]. To improve the quality of TCM research, some of the recommendations made by the group include the precise reporting of TCM interventions and outcome measures detailed as follows [ 22 , 23 ].

Precise Reporting of TCM Interventions in RCTs

• name, dosage format, and registration;
• composition and quality of intervention;
• pharmaceutical processing and quality control;
• stability of final product and quality control;
• function and safety description;
• dosage and treatment course;
• control group.
• name of active compound(s);
• original source of active compounds(s);
• the brief process obtaining active compound(s);
• percentage of active compound in final product;
• added materials and their quality and quantity control.

Precise Reporting of Outcome Measures of RCTs of TCM

• Identifying the primary and secondary outcomes based on the purpose and hypothesis of the trial;
• defining the primary and secondary outcomes clearly;
• presenting the rationale of selection;
• presenting the method with aims to standardize the assessment process;
• presenting the method to improve the reliability of assessment;
• stating the termination criteria in the trial.

More recently in 2009, the Good Practice in Traditional Chinese Medicine Research Association was launched. This was the European Union's first coordination action dedicated to TCM research, funded by the European Commission under its 7th Framework Programme to coordinate EU-China dialogues and collaborations in TCM research. This project has since engaged more than 200 scientists and clinicians in discussions on good practice issues related to various aspects of Chinese herbal medicine and acupuncture research [ 24 ].

5. Examples of Level 1 Evidences Supporting TCM Intervention

Despite the paucity of high quality evidences available, there are nevertheless a few examples of well-conducted RCTs with precise reporting, which attested to the feasibility of producing high quality evidence for TCM and provided valuable insight into this challenging undertaking.

5.1. Efficacy of TCM Formulation in Irritable Bowel Syndrome, 1998

In a study on patients with irritable bowel syndrome (IBS) [ 25 ], patients were randomly allocated to 1 of 3 treatment groups: individualized Chinese herbal formulations ( n = 38), a standard 20-herb Chinese herbal formulation ( n = 43), or placebo ( n = 35), all in capsule form. Patients were treated for 16 weeks and evaluated regularly by a traditional Chinese herbalist and a gastroenterologist. In this randomized, double-blinded, placebo-controlled trial, TCM formulation was shown to be effective in the management of IBS. Patients who received the standard formulation fared best during the course of treatment, while patients who received the individualized formulations maintained their improvement up to 14 weeks beyond the treatment period. This study is a good illustration of the potential efficacy of TCM for common conditions such as IBS which to date has no good solution by Western medicine other than symptomatic treatment. One unique feature of this study is that it compared the effect of standardized TCM formulation with individualized formulation. TCM practice has always emphasized on individualized treatment and syndrome-directed modification of TCM formulation regularly throughout the course of treatment, which may not be cost-effective or convenient from the patients' perspective. Further trials incorporating such comparisons would help to shed light on the relative superiority of customized treatment over standard formulation.

5.2. Efficacy of Maxingshigan-Yinqiaosan as Compared to Oseltamivir in Treating H1N1 Influenza, 2011

A prospective, nonblinded, randomized, controlled, multicenter trial was conducted in young patients in eleven hospitals from 4 provinces in China to compare the efficacy and safety of Oseltamivir and a TCM decoction “Maxingshigan-Yinqiaosan” in treating uncomplicated H1N1 influenza [ 26 ]. “Maxingshigan-Yinqiaosan” is a 12-herb formulation combining two classical TCM formulae for their “diaphoretic and heat-clearing” activities to treat respiratory tract infection. Subjects were randomized into four groups: Oseltamivir group ( n = 102), Maxingshigan-Yinqiaosan group ( n = 103), Oseltamivir plus Maxingshigan-Yinqiaosan group ( n = 102), and control group with no intervention ( n = 103). The study found that Oseltamivir and “Maxingshigan-Yinqiaosan,” whether used alone or in combination over a course of 5 days, resulted in a comparable time to fever resolution in patients with H1N1 influenza virus infection, superior to control group. This data therefore suggests that “Maxingshigan-Yinqiaosan” may be used as an alternative treatment to Oseltamivir for H1N1 influenza virus infection. This trial also illustrates two important facts: that the TCM formulation is as effective as Oseltamivir and that it is safe to be used in combination with Oseltamivir. The former is of relevance in terms of cost consideration, and the latter is relevant in terms of safety for the common layman practice of consuming both Western and traditional medicines with the hope of attaining enhanced therapeutic effect.

5.3. CHInese Medicine Neuroaid Efficacy on Stroke Recovery (CHIMES) Study, 2013

MLC601 (Trade name: Neuroaid) is a TCM formulation “Danqipiantan jiaonang” containing 9 herbs and 5 animal components [ 27 ]. A systematic review of six RCTs provided evidence that MLC601 could be effective in improving functional independence and motor recovery as an add-on to standard treatment and is safe for patients with primarily nonacute stable stroke [ 28 ]. The CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES) study, a multicentre, randomized, double-blinded, placebo-controlled trial ( n = 1099) comparing MLC601 with placebo in patients with acute ischemic stroke of intermediate severity in the preceding 72 hours, is one of the largest-scale TCM trials in the recent years with subject recruitment from various countries in South East Asia [ 29 ]. Although MLC601 is statistically no better than placebo in improving outcomes at 3 months when used among patients with acute ischemic stroke of intermediate severity, a post hoc analysis found that the MLC601 group had significantly less early vascular events compared to the placebo group [ 30 ]. The safety profile of MLC601 was also validated by the lack of significant difference in adverse events between treatment and placebo group. This study illustrated a few important lessons: while dispelling unrealistic hope on expedited recovery, it revealed the unexpected findings of reduced vascular events of a magnitude much larger than what aspirin has been shown to produce [ 31 ]. It also exemplified a well-conducted cum precisely reported TCM trial done in compliance with good clinical practices. Results from the ongoing extension study [ 32 ] investigating the longer-term efficacy over a 2-year follow-up from the initial course of intervention are eagerly awaited. A positive finding will be indicative of the value in conducting long-term assessments after initial short-course therapy, a method which may be relevant in evaluating TCM efficacy since TCM interventions aim at restoring balance and may thus have the potential to achieve long-term and sustained benefit rather than temporary symptomatic relief.

5.4. Efficacy of Tianqi Capsule in Patients with Impaired Glucose Tolerance, 2014

In a double-blind, randomized, placebo-controlled, multicenter trial, Tianqi capsule containing 10 TCM herbs was found to significantly decrease the incidence of progression to type 2 diabetes mellitus in subjects with impaired glucose tolerance, after a course of 12-month treatment ( n = 210) as compared with the placebo group ( n = 210) [ 33 ]. This particular study is laudable in that it reported in detail the subject inclusion and exclusion criteria and the randomization and blinding method as well as adverse events, which are often omitted or not elaborated on in most TCM clinical studies. It also conducted and described the chemical analysis of the composition of Tianqi capsule, quantifying the constituents of the formulation, which is in line with the precise reporting recommendations to improve the quality of TCM studies [ 22 ].

5.5. Efficacy of Acupuncture for Pain Management Based on Systematic Reviews

A Cochrane review of 33 trials ( n = 2293) found consistent evidence that acupuncture provides additional benefit in the treatment of acute migraine attacks compared to routine care and that acupuncture is at least as effective as or possibly more effective than prophylactic drug treatment and has fewer adverse effects. The review recommended acupuncture as a possible treatment option for patients who are willing to undergo this treatment [ 34 ]. Another review of 11 trials ( n = 2317) also concluded that acupuncture could be a valuable nonpharmacological tool in patients with frequent episodic or chronic tension-type headaches [ 35 ]. A review on efficacy of acupuncture on neck pain concluded that there is also moderate evidence that acupuncture is better at relieving neck pain compared with some sham treatments. It found that at short-term follow-up, patients who received acupuncture reported less pain than those on a waiting list and that acupuncture is more effective than inactive treatments for relieving pain after treatment and this effect is maintained at short-term follow-up [ 36 ]. A systematic review (12 trials, n = 1763) reported that acupuncture use is associated with significant reductions in pain intensity and improvement in functional mobility as well as quality of life in patients with osteoarthritis [ 37 ].

While these level 1 evidences on the whole prove the efficacy of certain TCM treatments, one shortcoming among these studies is the lack of incorporation of TCM principles in the study design. For example, with the exception of the IBS study, the principal concept of “Syndrome Differentiation” which guides TCM diagnosis and treatment was not applied. Subjects were recruited based on their diagnosis by Western medicine without further subcategorization into different TCM syndromes for which different formulations would be required correspondingly. Under such circumstances, the assessment of the efficacy of TCM treatment may be flawed because the methodology does not replicate the real-life practice of TCM, and any lack of efficacy demonstrated could arguably be a result of the deviation from the well-tested TCM principles. As advocated by some, study designs guided by TCM theory are necessary to validate and improve future RCTs in TCM [ 38 ].

6. Current Status of Available Evidence on Safety Issues of TCM Usage

Efficacy issues aside, one much neglected aspect of TCM is the safety issues of its usage, for which there is currently little available evidence but warrants great attention. We believe that the prerequisite for TCM to be accepted into mainstream healthcare lies in addressing the safety concerns including adverse herb reaction and herb-drug interactions. The following sections therefore elaborate on evidence available on the safety aspects of TCM.

As highlighted by the Chinese CONSORT for TCM, it is important for RCTs to transparently report not only efficacy but also all the related adverse effects [ 39 ]. In general, adverse effects (AE) of the TCM interventions can be classified into 5 types as summarized below [ 39 ]. We will discuss more toxicity inherent to the herbs and the important issue of herb-drug interaction.

Types of Adverse Effects of TCM Interventions

• AEs under proper TCM principles and guidelines, for example, acute/chronic toxicity and allergy;
• AEs due to improper usage without following TCM principles, involving without following the TCM therapeutic principles, over-dosage, improper processing and preparation methods, and improper formula strategy;
• AEs due to contamination, such as heavy metal and pesticides contaminations in TCM interventions and intentional or unintentional contamination with drugs;
• AEs due to replacement of TCM herbs;
• AEs due to drug-herb interaction.

6.1. Toxicity

Evidence of adverse effects can come from various levels, from careful monitoring in RCTs, to case series and case reports on observed toxicity. Evidence from animal or in vitro studies may be deemed as low level from the perspective of proving efficacy, but their role in providing safety information is much greater. Biomedical research on herb pharmacology and toxicity are crucial to ensure the safe and appropriate use of herbs. Conclusive evidences from modern studies should be continually updated into the Chinese herbal pharmacopoeia and taken into consideration in the current practice of TCM regardless of whether they were mentioned in ancient Chinese literature.

“Chinese Herb Nephropathy” is the unfortunate term coined after the misuse of Guang Fang Ji ( Aristolochia fangchi ) instead of Han Fang Ji ( Stephania tetrandra ) in slimming pills in a few European centers, which led to interstitial nephritis, renal failure, and urothelial carcinoma [ 40 ]. This is an example of evidence of toxicity learned the hard way. While ancient TCM literature did not caution against such toxicity, with modern technology we now know that Aristolochic acid is one of the most potent carcinogens known [ 41 ]. Such evidence of toxicity based on laboratory research is most clinically relevant and the physician's knowledge of such should prevent catastrophic adverse effects in clinical practice.

Another example of toxic alkaloids found in TCM herbs which are still widely used clinically is aconitine which is found in Aconitum species such as Fuzi/Chuanwu ( Aconitum carmichaelii ) and Caowu ( Aconitum kusnezoffii ). These herbs are often used for their analgesic and cardiotonic properties. Aconitine poisoning resulting from overdosing or inappropriate processing of herbs before consumption could lead to cardiovascular, gastrointestinal, and neurological toxicities such as palpitations, arrhythmias, hypotension, and perioral and limb paraesthesia [ 42 , 43 ]. Another known toxic herbal compound is ephedrine, the main active ingredient in Mahuang ( Ephedra sinica ) which is frequently used in respiratory condition for its antiasthmatic activity. Studies have found that misusing Mahuang at higher dosages could lead to hypertension and cardiac arrhythmia due to its sympathomimetic activity [ 44 ]. These are examples where the known pharmacological and toxicological properties of herbs, corroborated by even small case series which are low in the hierarchy in the pyramid of evidence levels, can constitute important evidence for developing guidelines on the safe dosage and contraindications in the use of herbs.

Apart from the above examples which are known to have toxicities, certain TCM herbs which are not known to be toxic may also pose health risks if consumed inappropriately. For example, Gancao ( Glycyrrhiza uralensis ) is a frequently used herb in TCM formulations for its Qi -tonifying effect. However, evidence provided from biochemical studies demonstrated that Gancao has corticosteroidal activity. Glycyrrhizin, the principal active ingredient in Gancao, and its hydrolysed metabolite Glycyrrhetinic acid are inhibitors of the oxidative function of the 11 β -hydroxysteroid dehydrogenase, thereby preventing the metabolism of cortisol. As such, cortisol could then bind to mineralocorticoid receptors, leading to pseudoaldosteronism, resulting in hypertension and hypokalemia [ 45 ]. The clinical significance of this experimental finding was ascertained by a few adverse case reports of pseudoaldosteronism caused by consumption of Gancao at high doses [ 46 ]. Further work to better define the safe dose of Gancao in prolonged usage will provide important evidence for physicians to utilize this herb safely in modern day practice.

The use of Huang Lian ( Rhizoma coptidis ) and Huang Bai ( Cortex phellodendri ) and products containing the alkaloid Berberine has been prohibited in Singapore since 1972 based on sporadic cases and circumstantial evidence that Berberine could cause kernicterus in glucose-6-phosphate dehydrogenase (G6PD) deficient neonates. This ban was lifted four decades later, after an extensive review process by the local authority. Evidence came from scientific publications and surveillance of adverse reactions reported in the Asian countries which practise TCM; all of which did not suggest major safety concerns when Berberine was used appropriately, with the provision that it should still be avoided in infants and G6PD deficient individuals of all ages as well as pregnant and breastfeeding women [ 47 , 48 ]. This illustrates that continuous research and review of herb toxicity against its therapeutic potential based on current evidence are important in guiding the rational use of herbs.

6.2. Herb-Drug Interactions

In communities where Western medicine is the primary mode of treatment and TCM is supplementary, there is a high prevalence for concomitant use of both drugs and herbs, raising the safety concern of potential herb-drug interactions. Interactions between drugs and herbs can generally occur at the pharmacodynamics level, whether the herbs may potentiate or antagonize the biological activities of the drugs by acting on the same target or at the pharmacokinetics level, where herbs may affect the absorption, distribution, metabolism, or excretion of the drugs [ 49 , 50 ]. Specifically, herbs can induce or inhibit cytochrome P450 family proteins which are the main metabolizing enzymes or interfere with the efflux activity of P-glycoprotein which can actively pump absorbed drugs back into the intestinal lumen, thus affecting the bioavailability of concomitant drugs. This is of particular concern in patients who are taking drugs with narrow therapeutic index, for example, warfarin, cyclosporine A, and phenytoin, where certain herbs may potentially result in undesirable consequences of toxic effects or therapeutic failure [ 49 , 50 ]. While such interactions are better studied in herbs used in Western folk medicine, for example, St John's Wort, Echinacea, and Milk thistle [ 49 , 51 ], clinical evidence for the interaction potential of TCM herbs with drugs is hugely lacking and needs to be established clearly.

An example of possible adverse interaction is that between Danshen ( Salviae miltiorrhizae ) and warfarin, as demonstrated by some published evidences. Danshen is a TCM herb with “Blood-invigorating” property commonly used in cardiovascular conditions. There are case reports of patients stable on warfarin experiencing elevated international normalized ratio and bleeding after consuming Danshen-containing formulations [ 52 , 53 ]. Preclinical studies investigating the interaction between Danshen and warfarin reported that the herb extract inhibited warfarin hydroxylation and increased its concentration in rats [ 54 ]. Furthermore, there were in vitro studies reporting that Danshen extract inhibited platelet aggregation [ 55 ]. Such evidences serve to provide preliminary but crucial information alerting on the potential problems with certain herb-drug pairs, which will mandate close monitoring in both clinical trials and real-life practice involving such combinations.

Contrary to the common assumption, not all herb-drug interactions are necessarily harmful. For instance, a study investigating the potential pharmacokinetic and pharmacodynamics interactions of a TCM formula CMF1 (Yinqiaosan and Sangjuyin) with Oseltamivir found that the antiviral activity of the Oseltamivir was enhanced by the herbal combination in healthy volunteers ( n = 14) [ 56 ]. This suggests that the combined use of CMF1 and Oseltamivir could achieve a better therapeutic effect against influenza without compromising on safety. That said, more studies need to be done in this area to establish the information needed to guide the appropriate use of herbs in patients on concomitant drugs so that the therapeutic effect of either is not compromised and undesired toxic side effects can be avoided.

7. Approaches of Some Asian Countries

There are plenty of in vitro and animal studies exploring herb-drug interactions. However, much variation exists among the studies in aspects such as the methodology used and dose of herb tested resulting in inconclusive interpretations of the results collectively. Interpretation of these findings is further complicated by the incongruence of results, where the same herb could be reported in different studies to have opposing effects. Moreover, it is difficult to assess the clinical significance of these preliminary research findings. Nonetheless, it is essential that we maximize the use of what is available such that this mass of evidence is systematically collected and transcribed into meaningful databases to provide clinicians with an objective assessment of the current evidences and assist them in making an informed decision. With this as the main objective, we in the Singapore General Hospital established a Traditional Medicine Information Service (TMIS) in 2011 as an extension to the Drug Information Service in the Department of Pharmacy, with the committee formed by a medical doctor, pharmacists, and licensed TCM practitioner. TMIS provides evidence-based information on traditional medicines (TCM, Jamu, Ayurveda herbal medicine, etc.) by conducting literature searches and critically reviewing the current evidences. It has embarked on the development of a warfarin-herb interaction database which serves as readily available information for reference by pharmacists within the hospital. At the National University of Singapore, an online oncology drug interaction database “OncoRx” [ 57 ] has been developed by an informatics team led by a pharmacist to allow quick searches on interactions between different combinations of anticancer agents and herbal medicines.

In addressing the safety issue of TCM herbs, in Hong Kong, a multidisciplinary team consisting of a pharmacist, a chemical pathologist, a scientific officer, and a physician was formed to provide an advisory service on herbal safety to healthcare professionals of all public hospitals since 2000 [ 42 ]. As part of the investigation of adverse events associated with herbal products, the products and biologic samples would be screened for the presence of synthetic drugs and natural toxins, for example, aconitine, ephedrine, and aristolochic acids using various analytical tools [ 42 ].

On the national level, various Asian countries have their own adverse reaction reporting and capturing systems for TCM, mostly based on voluntary reporting. The Chinese SFDA has its system established in 1989 [ 58 ] and Taiwan has a similar reporting system established in 1998 [ 59 ], relatively late considering the long history of use of TCM in both countries. In Hong Kong, this aspect is governed by the territory-wide Drug and Poisons Information Bureau [ 42 ], while in Singapore the Health Sciences Authority has an Adverse Event Monitoring unit for the reporting and investigation of dubious products suspected to be linked with the adverse events [ 60 ]. These pharmacovigilance efforts have the primary objectives of ensuring public safety, but their databases built up over time should also be an invaluable source of preliminary evidence and serve as the basis for further laboratory and clinical research to establish definitive evidence of adverse reaction and herb-drug interactions.

8. Future Directions

Many issues surrounding the efficacy and safety of TCM use in modern society remain unresolved and these hinder the potential benefits of TCM from being safely and effectively harnessed. Applying EBM to TCM is vital for the traditional practice to gain acceptance by Western medical practitioners and become an integral component of the healthcare system. This is a necessary step when exploring TCM as cost-effective treatment options to help tackle healthcare issues such as functional diseases, chronic illnesses in ageing populations, and rising healthcare costs. High quality evidences via RCTs assessing efficacy and safety are needed to substantiate the use of TCM in suitable conditions.

However, EBM should not be rigidly imposed onto TCM but rather adapted with flexibility taking into consideration the unique characteristics of TCM practice. As advocated in a review by Tang, a pragmatic approach towards TCM research by adopting an efficacy-driven approach instead of the conventional mechanism-based approach may be more applicable to TCM. This approach starts with evaluating safety and efficacy in humans by RCTs, from which efficacious interventions are identified before undertaking studies on mechanisms and active substances. This would avoid unnecessary basic research on inefficacious interventions and better channel resources to further study beneficial treatments. Most importantly, this strategy may provide high-level evidence for the expedited recognition of effective TCM interventions [ 61 ].

With the advancement of technology and research tools, continuous effort in conducting rigorous research into toxicities and drug-interacting potential of herbs as well as correlation of laboratory findings with clinical observations are essential. This provides new insights about the herbs to help us utilize the herbs in a more rational and safe way in the modern clinical setting. Stringent quality control in the manufacturing of herbal products, strict regulatory controls on TCM herbal products, and active safety surveillance to detect adverse events are crucial to safeguard the risks that TCM users are exposed to.

There are many challenges in applying EBM to TCM, but these can be overcome by various approaches. In the era of advanced technology and EBM, with the wise application of basic and clinical research methodology to provide the relevant evidence, TCM as an ancient science and art is poised to be brought to a greater height for its ultimate mission of benefiting human health.

Acknowledgment

The first author is employed under the Traditional Medicine Information Service which is a project funded by the Ministry of Health Healthcare Quality Improvement & Innovation Fund.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Login to your account

Change password, your password must have 8 characters or more and contain 3 of the following:.

• a lower case character, 
• an upper case character, 
• a special character 

Password Changed Successfully

Your password has been changed

Create a new account

Can't sign in? Forgot your password?

Enter your email address below and we will send you the reset instructions

If the address matches an existing account you will receive an email with instructions to reset your password

Request Username

Can't sign in? Forgot your username?

Enter your email address below and we will send you your username

If the address matches an existing account you will receive an email with instructions to retrieve your username

• This Journal
•   
• Institutional Access

Cookies Notification

Our site uses javascript to enchance its usability. you can disable your ad blocker or whitelist our website www.worldscientific.com to view the full content., select your blocker:, adblock plus instructions.

• Click the AdBlock Plus icon in the extension bar
• Click the blue power button
• Click refresh

Adblock Instructions

• Click the AdBlock icon
• Click "Don't run on pages on this site"

uBlock Origin Instructions

• Click on the uBlock Origin icon in the extension bar
• Click on the big, blue power button
• Refresh the web page

uBlock Instructions

• Click on the uBlock icon in the extension bar

Adguard Instructions

• Click on the Adguard icon in the extension bar
• Click on the toggle next to the "Protection on this website" text

Brave Instructions

• Click on the orange lion icon to the right of the address bar
• Click the toggle on the top right, shifting from "Up" to "Down

Adremover Instructions

• Click on the AdRemover icon in the extension bar
• Click the "Don’t run on pages on this domain" button
• Click "Exclude"

Adblock Genesis Instructions

• Click on the Adblock Genesis icon in the extension bar
• Click on the button that says "Whitelist Website"

Super Adblocker Instructions

• Click on the Super Adblocker icon in the extension bar
• Click on the "Don’t run on pages on this domain" button
• Click the "Exclude" button on the pop-up

Ultrablock Instructions

• Click on the UltraBlock icon in the extension bar
• Click on the "Disable UltraBlock for ‘domain name here’" button

Ad Aware Instructions

• Click on the AdAware icon in the extension bar
• Click on the large orange power button

Ghostery Instructions

• Click on the Ghostery icon in the extension bar
• Click on the "Trust Site" button

Firefox Tracking Protection Instructions

• Click on the shield icon on the left side of the address bar
• Click on the toggle that says "Enhanced Tracking protection is ON for this site"

Duck Duck Go Instructions

• Click on the DuckDuckGo icon in the extension bar
• Click on the toggle next to the words "Site Privacy Protection"

Privacy Badger Instructions

• Click on the Privacy Badger icon in the extension bar
• Click on the button that says "Disable Privacy Badger for this site"

Disconnect Instructions

• Click on the Disconnect icon in the extension bar
• Click the button that says "Whitelist Site"

Opera Instructions

• Click on the blue shield icon on the right side of the address bar
• Click the toggle next to "Ads are blocked on this site"

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

The American Journal of Chinese Medicine

• Recommend to library
• Alert me on new issues
• Aims & Scope
• Editorial Board
• Sample Issue
• Abstracted & Indexed in
• Price Information
• Contact AJCM
• Submission Guidelines
• Open Access
• Peer Review Policy
• Ethical Policy
• Vol. 52 No. 04 CURRENT ISSUE pp.905-1213
• Vol. 52 No. 03 pp.583-904
• Vol. 52 No. 02 pp.291-581
• Vol. 52 No. 01 pp.1-289

AJCM Best Papers Award:

Traditional Chinese Herbal Medicine for Allergic Diseases: A Review Chenyang Ai, Yi Zou, Hao Liu, Zheqiong Yang, Jinlei Xi Am J Chin Med, 2023;51(4):779-806

Berberine Attenuates Hyperuricemia by Regulating Urate Transporters and Gut Microbiota Baixi Shan, Mingyu Wu, Ting Chen, Weiwei Tang, Ping Li, Jun Chen Am J Chin Med, 2022;50(8):2199

Register with us today to receive free access to the selected articles.

Editor’s Pick for AJCM

Traditional Uses, Phytochemistry, Pharmacology, Quality Control, Industrial Application, Pharmacokinetics and Network Pharmacology of Pogostemon cablin: A Comprehensive Review. 50(3): 691-721, 2022. Xu, FF; Cai, WN; (...); Liu, B.

Polyphenols from Chinese Herbal Medicine: Molecular Mechanisms and Therapeutic Targets in Pulmonary Fibrosis. 50(4): 1063-1094, 2022. Wang, L; Zhu, T; (...); Zhang, CF.

Neuroprotective Effects of Alpinia oxyphylla Miq against Mitochondria-Related Apoptosis by the Interactions between Upregulated p38 MAPK Signaling and Downregulated JNK Signaling in the Subacute Phase of Cerebral Ischemia-Reperfusion in Rats. 50(8), 2022. Tsai, YT; Huang, HC; (...); Cheng, CY

Protective Effects and Therapeutics of Ginsenosides for Improving Endothelial Dysfunction: From Therapeutic Potentials, Pharmaceutical Developments to Clinical Trials. 50(3): 749-772, 2022. Yang, F; Yang, MY; (...); Shao, JW.

Ginsenoside Rh2 Regulates the CFAP20DC-AS1/MicroRNA-3614-3p/BBX and TNFAIP3 Axis to Induce Apoptosis in Breast Cancer Cells. 50(6): 1703-1717, 2022. Park, JE; Ji, HW; (...); Kim, SJ

Fisetin Ameliorates Alcohol-Induced Liver Injury through Regulating SIRT1 and SphK1 Pathway. 50(8): 2022. Zhou, ZS; Kong, CF; (...); Sun, AT.

LATEST ARTICLES

Study on the chemical constituents, pharmacological activities, and clinical application of taxus.

• Xinyu Gao , 
• Yifan Guo , 
• Kuilin Chen , 
• Hanyi Wang , and 
• Weidong Xie

Acupuncture: An Overview on Its Functions, Meridian Pathways and Molecular Mechanisms

• Rong Han  and 

Chinese Medicine-Derived Salvianolic Acid B for Disease Therapy: A Scientometric Study

• Meina Zhao , 
• Wei Zhang , 
• Xingru Tao , 
• Dong Xu , and 
• Jingwen Wang

Gut Microbiota Regulation by Acupuncture and Moxibustion: A Systematic Review and Meta-Analysis

• Sun-Jeong Bae , 
• Yumi Jang , 
• Yejin Kim , 
• Ji-Han Park , 
• Jae-Hwan Jang , 
• Ju-Young Oh , 
• Sun-Young Jang , 
• Sora Ahn , and 
• Hi-Joon Park

Natural Products on Inflammatory Bowel Disease: Role of Gut Microbes

• Wen-Wen Cheng , 
• Bao-Hong Liu , 
• Xiao-Ting Hou , 
• Huan Meng , 
• Dan Wang , 
• Cheng-Hao Zhang , 
• Shuo Yuan , and 
• Qing-Gao Zhang

Insight of Chinese Herbal Medicine in Treating Osteoporosis: Achievements from 2013 to 2023

• Mingshuai Tan , 
• Qiang Li , 
• Bencheng Yang , 
• Sihan Wang , and 

MOST READ ARTICLES The most read articles in the last 3 years

The impact of artificial intelligence on traditional chinese medicine.

• Yulin Wang , 
• Xiuming Shi , 
• Thomas Efferth , and 

COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese–Western Medicine for the Management of 2019 Novel Coronavirus Disease

• Kam Wa Chan , 
• Vivian Taam Wong , and 
• Sydney Chi Wai Tang

Acupuncture Medical Therapy and its Underlying Mechanisms: A Systematic Review

• Jingyi Wen , 
• Yong Yang , 
• Jianxin Liu , 
• Enyin Li , 
• Jiayou Liu , 
• Ziwei Zhou , 
• Weihua Wu , and 

Quercetin Ameliorates Diabetic Kidney Injury by Inhibiting Ferroptosis via Activating Nrf2/HO-1 Signaling Pathway

• Yang Yang , 
• Yingjin Qiao , 
• Yifeng Zheng , 
• Xiaoyue Yu , 
• Fengxun Liu , 
• Hui Wang , 
• Bin Zheng , 
• Shaokang Pan , 
• Kaidi Ren , 
• Dongwei Liu , and 
• Zhangsuo Liu

Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine

• Cheng Peng , and 
• Jun-Rong Du

Chinese Medicine in the Treatment of Ulcerative Colitis: The Mechanisms of Signaling Pathway Regulations

• Shihao Zheng , 
• Tianyu Xue , 
• Bin Wang , 
• Haolin Guo , and 

MOST CITED ARTICLES The most cited articles in the last 3 years. Source: Crossref

Astragalus membranaceus : a review of its protection against inflammation and gastrointestinal cancers.

• Kathy K. Auyeung , 
• Quan-Bin Han , and 
• Joshua K. Ko

Positive Role of Chinese Herbal Medicine in Cancer Immune Regulation

• Sumei Wang , 
• Shunqin Long , 
• Zhiyin Deng , and 

Antidiabetic Potential of Flavonoids from Traditional Chinese Medicine: A Review

• Xiaofang Li , 
• Yu Zheng , 
• Haiying Lu , 
• Jinqi Li , 
• Lei Zhong , 
• Rongsheng Tong , 
• Zhongliang Jiang , 
• Jianyou Shi , and 

Alpha-Pinene Exhibits Anti-Inflammatory Activity Through the Suppression of MAPKs and the NF-κB Pathway in Mouse Peritoneal Macrophages

• Dae-Seung Kim , 
• Hyun-Ja Lee , 
• Yong-Deok Jeon , 
• Yo-Han Han , 
• Ji-Ye Kee , 
• Hyun-Jeong Kim , 
• Hyun-Ji Shin , 
• JongWook Kang , 
• Beom Su Lee , 
• Sung-Hoon Kim , 
• Su-Jin Kim , 
• Sang-Hyun Park , 
• Byung-Min Choi , 
• Sung-Joo Park , 
• Jae-Young Um , and 
• Seung-Heon Hong

Acupuncture for Pain Management: Molecular Mechanisms of Action

• Teng Chen , 
• Wen Wen Zhang , 
• Yu-Xia Chu , and 
• Yan-Qing Wang

Traditional Chinese Medicine for Alzheimer’s Disease and Other Cognitive Impairment: A Review

• Feixue Wang , 
• Zehui Li , 
• Nanyang Liu , 
• Meixia Liu , 
• Yun Wei , and 

The Application of Fermentation Technology in Traditional Chinese Medicine: A Review

• Wenxiang Fan , 
• Yun Jiang , 
• Chao Zhang , 
• Jianghua Li , 
• Wei Peng , and 

Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT

• Jie Wang , 
• Qiaoli Liu , 
• LiKai Xing , 
• Qingsong Zuo , 
• Yong Zhang , 
• Cao Chen , 
• Peihao Yin , and 

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

• View all journals
• Explore content
• About the journal
• Publish with us
• Sign up for alerts
• NEWS FEATURE
• 26 September 2018

Why Chinese medicine is heading for clinics around the world

• David Cyranoski 0

David Cyranoski reports for Nature from Shanghai, China.

You can also search for this author in PubMed   Google Scholar

Choi Seung-hoon thought he had an impossible assignment. On a grey autumn day in Beijing in 2004, he embarked on a marathon effort to get a couple of dozen representatives from Asian nations to boil down thousands of years of knowledge about traditional Chinese medicine into one tidy classification system.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

24,99 € / 30 days

cancel any time

Subscribe to this journal

Receive 51 print issues and online access

185,98 € per year

only 3,65 € per issue

Rent or buy this article

Prices vary by article type

Prices may be subject to local taxes which are calculated during checkout

Nature 561 , 448-450 (2018)

doi: https://doi.org/10.1038/d41586-018-06782-7

Manheimer, E. et al. J. Altern. Complement. Med. 15 , 1001–1014 (2009).

Article   PubMed   Google Scholar  

Chan, M. Science 346 , S2 (2014).

Google Scholar  

Grollman, A. P. et al. Adv. Mol. Toxicol. 3 , 211–227 (2009).

Article   Google Scholar  

Download references

Reprints and permissions

Related Articles

• Health care
• Medical research
• Personalized medicine
• Natural products

Pain: recognizing the power of non-pharmaceutical interventions

Outlook 25 SEP 24

A drug-free prescription for pain

How pain is misunderstood and ignored in women

How a ‘pain-o-meter’ could improve treatments

The gut microbiome and chronic pain

Could biomarkers mean better pain treatment?

CRISPR cures and cancer vaccines: researchers can help to shepherd them to market

Editorial 12 JUN 24

Faculty(Group Leaders or Principal Investigators) and Postdoc positions

Faculty and Postdoc positions are open all year.

Hangzhou, Zhejiang, China

The Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine(ZJUSS)

Tenure-track Assistant Professor in Modelling Plant Stress Responses

Become a tenure-track Assistant Professor focusing on modelling plant stress responses at Umeå Plant Science Centre and IceLab, Umeå University!

Umeå (Stad), Västerbotten (SE)

Umeå University (KBC)

Faculty Positions in Westlake University

Founded in 2018, Westlake University is a new type of non-profit research-oriented university in Hangzhou, China, supported by public a...

Westlake University

Faculty Position - Open Rank - Assistant/Associate/Professor

Atlanta, Georgia

Emory University

Editor (Quantum Physics and Quantum Technologies)

The Associate/Senior Editor role at Nature Communications is ideal for researchers who love science but feel that a career at the bench isn’t enough.

London or Madrid – hybrid working model

Springer Nature Ltd

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Quick links

• Explore articles by subject
• Guide to authors
• Editorial policies